文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

当前时代儿童心脏移植等待名单结局:儿科心脏移植学会数据库分析

Waitlist Outcomes for Pediatric Heart Transplantation in the Current Era: An Analysis of the Pediatric Heart Transplant Society Database.
PubMed 文献 · Circulation · 2024-06-28

本研究基于儿科心脏移植学会数据库,纳入2010至2021年间<18岁列入心脏移植等待名单的5974例患儿,分析等待名单死亡率(WM)。分析限于前12个月,结果显示1A状态患者WM负担显著,小体型、低eGFR、ECMO和机械通气与WM风险升高相关,而无先天性心脏病或VAD支持与WM降低相关。

要点

  • 1A状态患者等待名单死亡率存在显著异质性,需细化风险分层。
  • ECMO和机械通气在所有队列中均与等待名单死亡率升高相关。
  • 单心室先心病接受VAD支持者等待名单死亡率更高,而其他队列VAD支持与死亡率降低相关。

核心结论

  • 1A状态患者等待名单死亡率差异显著,当前分配系统可考虑纳入ECMO或机械通气支持、单心室先心病接受VAD支持以及小体型合并先心病、限制型心肌病或肥厚型心肌病等高风险因素。

研究设计与样本

  • 回顾性数据库分析,查询儿科心脏移植学会数据库,纳入2010年1月1日至2021年12月31日期间<18岁指示进行心脏移植的患者,共5974例,其中1A状态3928例、1B状态1012例、2状态963例、7状态65例;因第一年后WM低,分析限于等待名单前12个月。

主要发现

  • 在1A状态患者中,体型较小和eGFR较低者WM较高,而无先天性心脏病或 listing 时接受VAD支持者WM较低。
  • 在最小体型队列中,扩张型心肌病以外的心脏诊断是WM的危险因素;既往心脏手术在BSA 0.3-0.7 m²和>0.7 m²组中是危险因素。
  • VAD支持与较低WM相关,但在单心室队列中VAD与较高WM相关;ECMO和机械通气在所有队列中均与WM风险增加相关。

临床怎么用

  • 对1A状态等待者应评估ECMO、机械通气、单心室先心病合并VAD支持、小体型合并先心病/限制型/肥厚型心肌病等高WM风险因素,以指导分配政策优化。

局限性

  • 分析限于等待名单前12个月,因第一年后WM低;未报告多变量调整的具体结果及其他潜在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Waitlist mortality (WM) remains elevated in pediatric heart transplantation. Allocation policy is a potential tool to help improve WM. This study aims to identify patients at highest risk for WM to potentially inform future allocation policy changes. METHODS: The Pediatric Heart Transplant Society database was queried for patients <18 years of age indicated for heart transplantation between January 1, 2010 to December 31, 2021. Waitlist mortality was defined as death while awaiting transplant or removal from the waitlist due to clinical deterioration. Because WM is low after the first year, analysis was limited to the first 12 months on the heart transplant list. Kaplan-Meier analysis and log-rank testing was conducted to compare unadjusted survival between groups. Cox proportional hazard models were created to determine risk factors for WM. Subgroup analysis was performed for status 1A patients based on body surface area (BSA) at time of listing, cardiac diagnosis, and presence of mechanical circulatory support. RESULTS: In total 5974 children met study criteria of which 3928 were status 1A, 1012 were status 1B, 963 were listed status 2, and 65 were listed status 7. Because of the significant burden of WM experienced by 1A patients, further analysis was performed in only patients indicated as 1A. Within that group of patients, those with smaller size and lower eGFR had higher WM, whereas those patients without congenital heart disease or support from a ventricular assist device (VAD) at time of listing had decreased WM. In the smallest size cohort, cardiac diagnoses other than dilated cardiomyopathy were risk factors for WM. Previous cardiac surgery was a risk factor in the 0.3 to 0.7 m2 and >0.7 m2 BSA groups. VAD support was associated with lower WM other than in the single ventricle cohort, where VAD was associated with higher WM. Extracorporeal membrane oxygenation and mechanical ventilation were associated with increased risk of WM in all cohorts. CONCLUSIONS: There is significant variability in WM among status-1A patients. Potential refinements to current allocation system should factor in the increased WM risk we identified in patients supported by extracorporeal membrane oxygenation or mechanical ventilation, single ventricle congenital heart disease on VAD support and small children with congenital heart disease, restrictive cardiomyopathy, or hypertrophic cardiomyopathy.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Butts RJ, Toombs L, Kirklin JK, et al. Waitlist Outcomes for Pediatric Heart Transplantation in the Current Era: An Analysis of the Pediatric Heart Transplant Society Database. Circulation. 2024. PMID: 38939965. doi:10.1161/CIRCULATIONAHA.123.068189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。